LONDON BROKER RATINGS: UBS, Goldman and Citi say 'buy' Lloyds Banking
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More
| Price | 307.60p on 07-05-2026 at 11:09:51 |
|---|---|
| Change | 0.80p 0.26% |
| Buy | 307.80p |
| Sell | 307.40p |
| Last Trade: | Sell 507.00 at 307.60p |
| Day's Volume: | 79,936 |
| Last Close: | 306.80p |
| Open: | 299.80p |
| ISIN: | GB00BM8NFJ84 |
| Day's Range | 299.80p - 310.60p |
| 52wk Range: | 294.20p - 483.00p |
| Market Capitalisation: | £1.07b |
| VWAP: | 309.07868p |
| Shares in Issue: | 346.68m |
Breedon (BREE) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 507 | 307.60p | Automatic Execution |
12:07:59 - 07-May-26 |
| Sell* | 140 | 307.80p | Automatic Execution |
12:07:43 - 07-May-26 |
| Sell* | 146 | 307.80p | Automatic Execution |
12:07:43 - 07-May-26 |
| Sell* | 6 | 308.00p | Automatic Execution |
12:05:23 - 07-May-26 |
| Sell* | 150 | 308.20p | Automatic Execution |
12:04:17 - 07-May-26 |
| Sell* | 282 | 308.20p | Automatic Execution |
12:04:17 - 07-May-26 |
| Sell* | 918 | 308.20p | Automatic Execution |
12:04:17 - 07-May-26 |
| Buy* | 78 | 308.20p | Automatic Execution |
12:04:17 - 07-May-26 |
| Buy* | 208 | 308.20p | Automatic Execution |
12:04:17 - 07-May-26 |
| Buy* | 82 | 308.20p | Automatic Execution |
12:04:17 - 07-May-26 |
Breedon (BREE) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Apr 2026 3:14 pm | RNS | Total Voting Rights |
| 29th Apr 2026 5:01 pm | RNS | Result of AGM |
| 29th Apr 2026 7:00 am | RNS | AGM Trading Update |
| 16th Apr 2026 4:40 pm | RNS | Director/PDMR Shareholding |
| 14th Apr 2026 5:10 pm | RNS | Director/PDMR Shareholding |
| 10th Apr 2026 9:55 am | RNS | Holding(s) in Company |
| 9th Apr 2026 3:29 pm | RNS | Director/PDMR Shareholding |
| 9th Apr 2026 9:07 am | RNS | Holding(s) in Company |
| 8th Apr 2026 3:41 pm | RNS | Director/PDMR Shareholding |
| 7th Apr 2026 12:00 pm | RNS | Director/PDMR Shareholding |